Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machet

Showing results (241-250 of 377) with videos related to

Pageof 38
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2013
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patientsC Chabbert, H Adamski, G Guillet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 28, 2018
Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomasSarah Menguy, Eric Frison, Martina Prochazkova-Carlotti, et al.
Diagnostic and Interventional Imaging|December 4, 2014
Non-invasive diagnosis of intracranial aneurysmsC Rodriguez-Régent, M Edjlali-Goujon, D Trystram, et al.
Scientific Reports|October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Diagnostic and Interventional Imaging|January 30, 2015
Imaging of cervical artery dissectionW Ben Hassen, A Machet, M Edjlali-Goujon, et al.
JAMA Dermatology|March 8, 2023
Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical TrialPascal Joly, Audrey Lafon, Estelle Houivet, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2021
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenibPhilippe Saiag, Caroline Robert, Jean-Jacques Grob, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2022
An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastasesCaroline Dutriaux, Caroline Robert, Jean-Jacques Grob, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2013
Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patientsM Samimi, A Touzé, H Laude, et al.
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
Pageof 38

Showing results (241-250 of 377) with videos related to

Sort By:
Pageof 38
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2013
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patientsC Chabbert, H Adamski, G Guillet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 28, 2018
Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomasSarah Menguy, Eric Frison, Martina Prochazkova-Carlotti, et al.
Diagnostic and Interventional Imaging|December 4, 2014
Non-invasive diagnosis of intracranial aneurysmsC Rodriguez-Régent, M Edjlali-Goujon, D Trystram, et al.
Scientific Reports|October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Diagnostic and Interventional Imaging|January 30, 2015
Imaging of cervical artery dissectionW Ben Hassen, A Machet, M Edjlali-Goujon, et al.
JAMA Dermatology|March 8, 2023
Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical TrialPascal Joly, Audrey Lafon, Estelle Houivet, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2021
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenibPhilippe Saiag, Caroline Robert, Jean-Jacques Grob, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2022
An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastasesCaroline Dutriaux, Caroline Robert, Jean-Jacques Grob, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2013
Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patientsM Samimi, A Touzé, H Laude, et al.
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
Pageof 38